Late Breaking Clinical Science Abstracts

262 - Impact of Residual Secondary Mitral Regurgitation on Clinical Outcomes after LVAD Implantation: An Analysis from the MOMENTUM 3 Pivotal Trial and Continuous Access Protocol Study

Presentation Number
262
Speakers
Session Name
SESSION 71 - ORAL: Valve Regurgitation in MCS Patients
Date
Sat, Apr 25, 2020
Time
08:15 AM - 10:00 AM
Authors

Previous ePresentation
256 - Circulating Exosomes from Human Lung Transplant Recipients Having Respiratory Viral Infections Contain Nucleic Acids and Activate Signaling Pathways CGAS/STING and RIG-1

Next ePresentations
263 - Morphologic and Functional Changes after LVAD Implantation in Patients with Preoperative Severe Mitral Regurgitation
266 - Impact of Progressive Aortic Regurgitation on Outcomes after Continuous Flow Left Ventricular Assist Device Implantation
271 - Outcomes of Heart Transplantation from Hepatitis C Seropositive Donors: An Updated Analysis of the United Network for Organ Sharing Registry
273 - Incidence of Acute Cellular Rejection in Heart Transplant Recipients from Hepatitis C Viremic Donors -- One-Year Follow-Up
274 - Cardiac Allograft Vasculopathy in Heart Transplant Recipients from Hepatitis C Viremic Donors
276 - Thoracotomy Approach is Associated with Less Right Ventricular Failure and Shorter Length of Stay: An Intermacs Analysis of Nearly 1000 Implants via Thoracotomy
277 - Combining Ultrafast Anaesthesia and Minimal Invasive Implantation in HeartMate 3: A Pilot Study
279 - Concomitant Cardiac Procedures during Implantation of Long-Term Continuous-Flow LVADs: A European Registry for Patients with Mechanical Circulatory Support (EUROMACS) Analysis
282 - Depressive Symptoms in Lung Transplant Recipients: Trajectory and Association with Mortality
283 - The Effect of the Cystic Fibrosis Care Center on Lung Transplant Outcomes